$73.80
2.74% day before yesterday
NYSE, Jul 11, 10:10 pm CET
ISIN
US83444M1018
Symbol
SOLV
Index
Sector

Solventum Stock price

$73.80
-0.61 0.82% 1M
+5.29 7.72% 6M
+7.74 11.72% YTD
+24.44 49.51% 1Y
-6.20 7.75% 3Y
-6.20 7.75% 5Y
-6.20 7.75% 10Y
-6.20 7.75% 20Y
NYSE, Closing price Fri, Jul 11 2025
-2.08 2.74%
ISIN
US83444M1018
Symbol
SOLV
Index
Sector

Key metrics

Basic
Market capitalization
$12.8b
Enterprise Value
$20.1b
Net debt
$7.4b
Cash
$534.0m
Shares outstanding
173.0m
Valuation (TTM | estimate)
P/E
33.9 | 13.0
P/S
1.5 | 1.5
EV/Sales
2.4 | 2.3
EV/FCF
53.0
P/B
3.9
Financial Health
Equity Ratio
20.5%
Return on Equity
16.2%
ROCE
7.0%
ROIC
8.3%
Debt/Equity
2.4
Financials (TTM | estimate)
Revenue
$8.3b | $8.6b
EBITDA
$1.4b | $2.0b
EBIT
$832.0m | $1.7b
Net Income
$379.0m | $984.2m
Free Cash Flow
$380.0m
Growth (TTM | estimate)
Revenue
-18.7% | 4.1%
EBITDA
-50.3% | 22.1%
EBIT
-59.9% | 56.6%
Net Income
-76.1% | 105.5%
Free Cash Flow
-80.7%
Margin (TTM | estimate)
Gross
54.7%
EBITDA
16.6% | 23.5%
EBIT
10.0%
Net
4.6% | 11.5%
Free Cash Flow
4.6%
More
EPS
$2.2
FCF per Share
$2.2
Short interest
3.0%
Employees
-
Rev per Employee
-
Show more

Is Solventum a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Solventum Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Solventum forecast:

8x Buy
42%
10x Hold
53%
1x Sell
5%

Analyst Opinions

19 Analysts have issued a Solventum forecast:

Buy
42%
Hold
53%
Sell
5%

Financial data from Solventum

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
8,308 8,308
19% 19%
100%
- Direct Costs 3,763 3,763
13% 13%
45%
4,545 4,545
23% 23%
55%
- Selling and Administrative Expenses 2,950 2,950
4% 4%
36%
- Research and Development Expense 763 763
20% 20%
9%
1,377 1,377
50% 50%
17%
- Depreciation and Amortization 545 545
22% 22%
7%
EBIT (Operating Income) EBIT 832 832
60% 60%
10%
Net Profit 379 379
76% 76%
5%

In millions USD.

Don't miss a Thing! We will send you all news about Solventum directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Solventum Stock News

Neutral
PRNewsWire
25 days ago
Recognized among the top 25 percent of companies in healthcare and research, and top 25 percent of companies in the Midwest in just 14 months as a new company Award highlights success in phase one of Solventum's  three-phased Transformation Plan ST. PAUL, Minn.
Neutral
PRNewsWire
about one month ago
ST. PAUL, Minn. , June 3, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today its executives will participate in a fireside chat at the Goldman Sachs 46th Annual Global Health Care Conference on Tuesday, June 10, 2025, beginning at approximately 4:00 p.m.
Neutral
Seeking Alpha
2 months ago
Solventum Corporation (NYSE:SOLV ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Amy Wakeham - Senior Vice President of Investor Relations & External Finance Communications Bryan Hanson - Chief Executive Officer Wayde McMillan - Chief Financial Officer Conference Call Participants Patrick Wood - Morgan Stanley Frederick Wise - Stifel, Nicolaus & Company, Inc. Jaso...
More Solventum News

Company Profile

Solventum Corp. operates as a health care company. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.

Head office United States
CEO Bryan Hanson
Website www.solventum.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today